AtriCure

Headquarters: West Chester, Ohio, United States, North America

Region: Ohio

Country: US

Continent: North America

AtriCure is a medical device company focused on atrial fibrillation treatment and related cardiac therapies. It specializes in surgical ablation solutions and Left Atrial Appendage Management (LAAM), including the AtriClip devices, to reduce Afib-related stroke risk and improve rhythm outcomes. Headquartered in Mason, Ohio, with a global presence across the United States and international regions, the company also markets minimally invasive instruments and adjunct technologies for hybrid AF therapy and epicardial access. AtriCure emphasizes education, clinical evidence, and patient-centric care for healthcare professionals and patients managing Afib and post-operative pain management.

AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation and related cardiac conditions. Its products include surgical ablation systems, left atrial appendage exclusion devices, and cryoablation probes used by electrophysiologists and cardiothoracic surgeons. The company serves healthcare professionals managing Afib and post-operative pain.

Primary Industry: Manufacturing